RECRUITING

The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System Function

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Low level transcutaneous vagus nerve stimulation (LLTS) involves delivery of electrical impulses transcutaneously at the auricular branch of vagus nerve and it has been shown to have anti-inflammatory and anti-arrhythmic effects. In previous studies from our laboratory, we found that LLTS significantly suppressed atrial fibrillation (AF) inducibility and decreased AF duration. The anti-arrhythmic effects of LLTS were similar to those delivered to the cervical VN trunk. LLTS for just one hour significantly shortened the AF duration and decreased inflammatory cytokines. We have also shown that LLTS leads to favorable heart rate variability (HRV) changes and cardiac mechanics in patients with diastolic dysfunction. These results support the use of LLTS as a novel non-pharmacological, non-ablative treatment modality for AF and possibly other inflammatory conditions. However, the optimal stimulation parameters of LLTS remain to be determined. In this study, we aim to examine the effect of 2 different frequencies (5Hz and 20Hz) and 2 different amplitudes (50% below the pain threshold and 1mA below the pain threshold) of LLTS on heart rate variability with deep breathing (HRVdb), mental arithmetic stress test (MAST), frequency domain measures of heart rate variability (HRV) and brain stem evoked potentials (BSEVP) in healthy volunteers and patients with AF or heart failure with preserved ejection fraction (HFpEF). HRV is a marker of vagus nerve activity and can be easily measured by software calculating the distance between consecutive R waves on the ECG. BSEVP are a surrogate for the central projections of the vagus nerve. Patients will be randomized into 4 groups in a 2x2 factorial design. LLTS will be delivered through a transcutaneous electrical nerve stimulation (TENS) device for 15 minutes. HRVdb, HRV and BSEVP will be measured before and after LLTS and compared.

Official Title

The Effect of Different Low-Level Tragus Stimulation Parameters On Autonomic Nervous System Function

Quick Facts

Study Start:2021-11-30
Study Completion:2025-02
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT04682704

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 90 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Male and female patients older than 21 year old
  2. 2. Healthy volunteers free from diagnosis of AF, heart failure, coronary artery disease or diseases that affect the autonomic nervous system.
  3. 3. Patients with Paroxysmal Atrial Fibrillation
  4. 4. Patients with Heart Failure with Preserved Ejection Fraction (HFpEF)
  1. 1. Recent (\<6 months) stroke
  2. 2. Recent (\<6 months) myocardial infarction
  3. 3. Heart failure (NYHA class III or IV)
  4. 4. Left ventricular ejection fraction \<50%
  5. 5. Recurrent vaso-vagal syncopal episodes
  6. 6. Unilateral or bilateral vagotomy
  7. 7. Pregnancy or breast feeding
  8. 8. Uncontrolled diabetes or hypertension
  9. 9. Inability or unwillingness to understand and/or sign informed consent
  10. 10. Any serious disease that affects autonomic nervous system function
  11. 11. Any medications that affect autonomic nervous system function

Contacts and Locations

Study Contact

Karrie Meeks
CONTACT
4052714742
karrie-meeks@ouhsc.edu

Principal Investigator

Stavros Stavrakis, MD, PhD
PRINCIPAL_INVESTIGATOR
University of Oklahoma

Study Locations (Sites)

University of Oklahoma Health Sciences Center
Oklahoma City, Oklahoma, 73104
United States

Collaborators and Investigators

Sponsor: University of Oklahoma

  • Stavros Stavrakis, MD, PhD, PRINCIPAL_INVESTIGATOR, University of Oklahoma

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2021-11-30
Study Completion Date2025-02

Study Record Updates

Study Start Date2021-11-30
Study Completion Date2025-02

Terms related to this study

Additional Relevant MeSH Terms

  • Atrial Fibrillation
  • Heart Failure, Diastolic